PMVP | tickerfilter.com

Fundamental analysis

16%

Profitability 0%

Dept financing 28%

Liquidity 50%

Performance 20%

Company vs Stock growth

+ Add row to compare

Performance

5 Days

0 0%

1 Month

-12.14%

3 Months

-21.66%

6 Months

-18.54%

1 Year

-24.54%

2 Year

-77.76%

Key data

Stock price

$1.23

P/E Ratio

0.00

DAY RANGE

$1.20 - $1.28

EPS

-$1.07

52 WEEK RANGE

$1.20 - $2.26

52 WEEK CHANGE

-$25.45

MARKET CAP

78.138 M

YIELD

N/A

SHARES OUTSTANDING

51.520 M

DIVIDEND

N/A

EX-DIVIDEND DATE

N/A

NEXT EARNINGS DATE

N/A

BETA

0.88

PUBLIC FLOAT

AVERAGE 10 VOLUME

$216,975

AVERAGE 30 VOLUME

$147,145

Company detail

CEO: David H. Mack
Region: US
Website: pmvpharma.com
Employees: 50
IPO year: 2020

Issue type: Common Stock
Market: XNAS
Industry: Pharmaceutical Products/Pharmaceutical Preparations
Sector: Manufacturing

PMV Pharmaceuticals, Inc. engages in the discovery and development of small molecule and tumor-agnostic therapies for p53 mutations in cancer. The company's lead product candidate is PC14586, a small molecule that corrects a p53 protein containing the Y220C mutation and restores wild-type p53 function.

PMVP - PMV Pharmaceuticals, Inc.